Charles Mosseri - May 12, 2025 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
10%+ Owner
Signature
/s/ Charles Mosseri-Marlio
Stock symbol
NVCT
Transactions as of
May 12, 2025
Transactions value $
$171,664
Form type
4
Date filed
5/13/2025, 06:36 PM
Previous filing
May 12, 2025
Next filing
Jun 20, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mosseri Marlio Charles 10%+ Owner 27 RIPPLEVALE GROVE, LONDON, LIBYAN ARAB JAMAHIRIYA /s/ Charles Mosseri-Marlio 2025-05-13 0001806384

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $172K +21.2K +0.72% $8.11 2.94M May 12, 2025 By Emerald Hill Ventures SARL SPF. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average purchase price. The range of prices for the shares purchased was $8.11 to $8.12. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.